HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan · Delayed Price · Currency is TWD 60.80
-0.90 (-1.46%)
At close: Apr 17, 2026
HeXun Biosciences Company Description
HeXun Biosciences Co., Ltd. engages in the research and development of stem cell drug development and cardiovascular disease treatments in Taiwan.
It provides contract manufacturing; commissioned inspection; aseptic filling; and consulting services.
The company was founded in 2019 and is based in Taoyuan City, Taiwan.
HeXun Biosciences Co., Ltd.
| Country | Taiwan |
| Founded | 2019 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 45 |
| CEO | Ji-Hong Huang |
Contact Details
Address: No. 1490, Chunri Road Taoyuan City, 33022 Taiwan | |
| Phone | 886 3 317 5088 |
| Website | hexunbio.com |
Stock Details
| Ticker Symbol | 6986 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006986003 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Ji-Hong Huang | President and Chairman |
| Yushen Lan | Accounting and Finance Director |
| Arvin Chen | Vice President of Technology Management |
| Fred Cheng | Director of Administration |